| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requester: Very Good Fit; Would be placed in a rotation with other fungicides with different modes of action to prevent resistance:08/23; VERY GOOD FIT: SAME: WSR; VERY GOOD FIT: SEE PREV COMMENT.: SOR
|
| Reasons for need: |
anthracnose; Limits on copper use and limited alternatives, needed for resistance management
|
| Requesting State(s): |
CA:Arpaia, M ; FL:Crane, J* ;
|
| PCR Use Pattern: |
Apply Quadris Top as a foliar spray up to 4 times at 12-14 fl oz/A every 7-10 days; PHI = 0 days
|
| EPA Default Residue Trials: |
3 10-4
|
| IR-4 Residue Trial Plan: |
UP TO 3 TRIALS IN 13 AND A MINIMUM OF 2 TRIALS IN 10; NEED A TOTAL OF 5 TRIALS;1 DECLINE. 2025 - 2025 - 2 RED A (1 NEED & 1 BACKUP) TRIAL
|
| Residue Protocol Use Pattern: |
USE THE QUADRIS TOP PRODUCT (1.67 LB AZOXY AI + 1.05 LB DIFEN AI PER GAL); MAKE 4 FOLIAR DIRECTED APPLIC OF 415 ML PROD/A (0.115 LB AI/A DIFEN + 0.183 LB AI/A AZOXY) IN 80-200 GPA, 10-DAY INTERVAL, 0-DAY PHI; ALL APPLIC SHALL INCLUDE A LABELED RATE OF AN NIS OR COC ADJUVANT
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
IN THE 2024 PERFORMANCE PROTOCOL: TESTING THE QUADRIS TOP PRODUCT (1.05 LB AI DIFENOCONAZOLE AND 1.67 LB AI AZOXYSTROBIN/GAL) VS A LABELED STANDARD FOR ANTHRACNOSE CONTROL AND CROP SAFETY DATA; MAKE 4 FOLIAR DIRECTED APPLIC OF 415 ML PRODUCT/A IN 80-200 GPA AT 10-DAY INTERVALS, 0-DAY PHI; PLOTS SHOULD BE INOCULATED WITHIN 2 DAYS OF FUNGICIDE APPLIC IF NATURAL INOCULUM IS NOT PRESENT; ALL APPLIC SHALL INCLUDE A LABELED RATE OF AN ADJUVANT; EVALUATE FOLIAR DISEASE SEVERITY, FRUIT DISEASE INCIDENCE AND SEVERITY AND FRUIT AND FOLIAGE INJURY
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
Orange 09/23;
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
Mfg supports as "Potential: E/CS Data Before Approval for Residue:08/23; EPA Hold Caution at 2023 FUW:09/23/sb; Syngenta will now support for Res & E/CS concurrently, so the category has been updated from Potential: E/CS Data before Approval For Res, to Researchable, Residue & E/CS Data Needed, and IR-4 has approved both Res & E/CS to move forward in 2024, and the Priority has been changed from H to A:02/24/sb; Status changed from "Researchable, Residue & E/CS Data Needed" to "complete w ongoing trials" 05/24/drs; Status updated to "res ongoing, ecs ongoing" 06/24/drs;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|